MedPAC To The Rescue? How US Policy Advisors Could Save The Drug Industry

 
• By Michael McCaughan

The Congressionally-chartered Medicare Payment Advisory Commission is preparing a formal endorsement of a plan to overhaul Part D. It will come just in time to help move stalled legislation – and that legislation may be the best chance the drug industry has to fend off draconian pricing measures in 2021.

Letter D
Re-engineering Medicare Part D could help the pharma industry avoid more draconian price controls. • Source: shuttershock

More from Archive

More from Pink Sheet